| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5733368 | Journal of the American College of Surgeons | 2017 | 27 Pages |
Abstract
Our results validate pancreatic cyst fluid PGE2 as an indicator of IPMN dysplasia, especially in select patients with preoperative pancreatic cyst fluid CEA >192 ng/mL. The inclusion of PGE2/CEA in a diagnostic biomarker panel can facilitate more optimal treatment stratification of IPMN patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Michele T. PhD, Rosalie A. MD, Huangbing BS, C. Max MD, MBA, PhD, FACS,